container_end_page 95
container_issue 1-2
container_start_page 95
container_title Transplantation proceedings
container_volume 31
creator Chang, A.C
Blum, M.G
Blair, K.S.A
Scott, M.A
Brock, J.E
Thomas, D.W
Burkly, L.C
Miller, G.G
Pierson, R.N
description
doi_str_mv 10.1016/S0041-1345(98)01455-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69628312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134598014559</els_id><sourcerecordid>69628312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-594c8ee75a0fb4ff2ef7b6585671dce780da17cfc8aa348a69cb8d5c16f3cbc43</originalsourceid><addsrcrecordid>eNqFkE1r3DAQhkVoSTZpfkKKD6WkB6eSJdnyKYTtVyC0hTZnMR6NtipaeyN5F_Lv6_0gya2nYeB55-Nh7ELwK8FF_fEX50qUQip92ZoPXCity_aIzYRpZFnVlXzFZk_ICTvN-S-f-krJY3YiODeSV3rGvv9MQxz6BbkC-jGU80-KFzEsoHfF-IcSrB6LsFylYUO5WKWwhJEKhOQCYAExDosEfizyOm3CBuIb9tpDzHR-qGfs_svn3_Nv5d2Pr7fzm7sSZcvHUrcKDVGjgftOeV-Rb7paG103wiE1hjsQDXo0AFIZqFvsjNMoai-xQyXP2Pv93OmyhzXl0S5DRooRehrW2dZtXRkpqgnUexDTkHMib3dPpEcruN2KtDuRdmvJtsbuRNp2yr09LFh3S3IvUntzE_DuAEBGiD5BjyE_cw1vuNxi13uMJhubQMlmDNQjuZAIR-uG8J9L_gFK4ZAq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69628312</pqid></control><display><type>article</type><title>Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chang, A.C ; Blum, M.G ; Blair, K.S.A ; Scott, M.A ; Brock, J.E ; Thomas, D.W ; Burkly, L.C ; Miller, G.G ; Pierson, R.N</creator><creatorcontrib>Chang, A.C ; Blum, M.G ; Blair, K.S.A ; Scott, M.A ; Brock, J.E ; Thomas, D.W ; Burkly, L.C ; Miller, G.G ; Pierson, R.N</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(98)01455-9</identifier><identifier>PMID: 10083025</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Antibodies, Monoclonal - therapeutic use ; Biological and medical sciences ; CD40 Antigens - immunology ; CD40 Ligand ; Graft Rejection - immunology ; Graft Rejection - pathology ; Graft Survival - immunology ; Heart Transplantation - immunology ; Heart Transplantation - pathology ; Immunomodulators ; Immunosuppression - methods ; Ligands ; Lymphocytes - immunology ; Lymphocytes - pathology ; Macaca fascicularis ; Medical sciences ; Membrane Glycoproteins - antagonists &amp; inhibitors ; Membrane Glycoproteins - immunology ; Pharmacology. Drug treatments ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Transplantation, Homologous</subject><ispartof>Transplantation proceedings, 1999-02, Vol.31 (1-2), p.95-95</ispartof><rights>1999 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-594c8ee75a0fb4ff2ef7b6585671dce780da17cfc8aa348a69cb8d5c16f3cbc43</citedby><cites>FETCH-LOGICAL-c390t-594c8ee75a0fb4ff2ef7b6585671dce780da17cfc8aa348a69cb8d5c16f3cbc43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0041-1345(98)01455-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1707035$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10083025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, A.C</creatorcontrib><creatorcontrib>Blum, M.G</creatorcontrib><creatorcontrib>Blair, K.S.A</creatorcontrib><creatorcontrib>Scott, M.A</creatorcontrib><creatorcontrib>Brock, J.E</creatorcontrib><creatorcontrib>Thomas, D.W</creatorcontrib><creatorcontrib>Burkly, L.C</creatorcontrib><creatorcontrib>Miller, G.G</creatorcontrib><creatorcontrib>Pierson, R.N</creatorcontrib><title>Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Animals</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>CD40 Antigens - immunology</subject><subject>CD40 Ligand</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - pathology</subject><subject>Graft Survival - immunology</subject><subject>Heart Transplantation - immunology</subject><subject>Heart Transplantation - pathology</subject><subject>Immunomodulators</subject><subject>Immunosuppression - methods</subject><subject>Ligands</subject><subject>Lymphocytes - immunology</subject><subject>Lymphocytes - pathology</subject><subject>Macaca fascicularis</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - antagonists &amp; inhibitors</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Pharmacology. Drug treatments</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Transplantation, Homologous</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1r3DAQhkVoSTZpfkKKD6WkB6eSJdnyKYTtVyC0hTZnMR6NtipaeyN5F_Lv6_0gya2nYeB55-Nh7ELwK8FF_fEX50qUQip92ZoPXCity_aIzYRpZFnVlXzFZk_ICTvN-S-f-krJY3YiODeSV3rGvv9MQxz6BbkC-jGU80-KFzEsoHfF-IcSrB6LsFylYUO5WKWwhJEKhOQCYAExDosEfizyOm3CBuIb9tpDzHR-qGfs_svn3_Nv5d2Pr7fzm7sSZcvHUrcKDVGjgftOeV-Rb7paG103wiE1hjsQDXo0AFIZqFvsjNMoai-xQyXP2Pv93OmyhzXl0S5DRooRehrW2dZtXRkpqgnUexDTkHMib3dPpEcruN2KtDuRdmvJtsbuRNp2yr09LFh3S3IvUntzE_DuAEBGiD5BjyE_cw1vuNxi13uMJhubQMlmDNQjuZAIR-uG8J9L_gFK4ZAq</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Chang, A.C</creator><creator>Blum, M.G</creator><creator>Blair, K.S.A</creator><creator>Scott, M.A</creator><creator>Brock, J.E</creator><creator>Thomas, D.W</creator><creator>Burkly, L.C</creator><creator>Miller, G.G</creator><creator>Pierson, R.N</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990201</creationdate><title>Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival</title><author>Chang, A.C ; Blum, M.G ; Blair, K.S.A ; Scott, M.A ; Brock, J.E ; Thomas, D.W ; Burkly, L.C ; Miller, G.G ; Pierson, R.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-594c8ee75a0fb4ff2ef7b6585671dce780da17cfc8aa348a69cb8d5c16f3cbc43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>CD40 Antigens - immunology</topic><topic>CD40 Ligand</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - pathology</topic><topic>Graft Survival - immunology</topic><topic>Heart Transplantation - immunology</topic><topic>Heart Transplantation - pathology</topic><topic>Immunomodulators</topic><topic>Immunosuppression - methods</topic><topic>Ligands</topic><topic>Lymphocytes - immunology</topic><topic>Lymphocytes - pathology</topic><topic>Macaca fascicularis</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - antagonists &amp; inhibitors</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Pharmacology. Drug treatments</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, A.C</creatorcontrib><creatorcontrib>Blum, M.G</creatorcontrib><creatorcontrib>Blair, K.S.A</creatorcontrib><creatorcontrib>Scott, M.A</creatorcontrib><creatorcontrib>Brock, J.E</creatorcontrib><creatorcontrib>Thomas, D.W</creatorcontrib><creatorcontrib>Burkly, L.C</creatorcontrib><creatorcontrib>Miller, G.G</creatorcontrib><creatorcontrib>Pierson, R.N</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, A.C</au><au>Blum, M.G</au><au>Blair, K.S.A</au><au>Scott, M.A</au><au>Brock, J.E</au><au>Thomas, D.W</au><au>Burkly, L.C</au><au>Miller, G.G</au><au>Pierson, R.N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>31</volume><issue>1-2</issue><spage>95</spage><epage>95</epage><pages>95-95</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10083025</pmid><doi>10.1016/S0041-1345(98)01455-9</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 1999-02, Vol.31 (1-2), p.95-95
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_69628312
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Antibodies, Monoclonal - therapeutic use
Biological and medical sciences
CD40 Antigens - immunology
CD40 Ligand
Graft Rejection - immunology
Graft Rejection - pathology
Graft Survival - immunology
Heart Transplantation - immunology
Heart Transplantation - pathology
Immunomodulators
Immunosuppression - methods
Ligands
Lymphocytes - immunology
Lymphocytes - pathology
Macaca fascicularis
Medical sciences
Membrane Glycoproteins - antagonists & inhibitors
Membrane Glycoproteins - immunology
Pharmacology. Drug treatments
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Transplantation, Homologous
title Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A44%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20anti-CD40%20ligand%20therapy%20improves%20primate%20cardiac%20allograft%20survival&rft.jtitle=Transplantation%20proceedings&rft.au=Chang,%20A.C&rft.date=1999-02-01&rft.volume=31&rft.issue=1-2&rft.spage=95&rft.epage=95&rft.pages=95-95&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(98)01455-9&rft_dat=%3Cproquest_cross%3E69628312%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69628312&rft_id=info:pmid/10083025&rft_els_id=S0041134598014559&rfr_iscdi=true